Yamashiro, K.; Hamada, T.; Mori, K.; Nishi, K.; Nakamura, M.; Beppu, M.; Tanaka, A.; Hijioka, H.; Kamikawa, Y.; Sugiura, T.
Exosome-Derived microRNAs from Mouthrinse Have the Potential to Be Novel Biomarkers for Sjögren Syndrome. J. Pers. Med. 2022, 12, 1483.
https://doi.org/10.3390/jpm12091483
AMA Style
Yamashiro K, Hamada T, Mori K, Nishi K, Nakamura M, Beppu M, Tanaka A, Hijioka H, Kamikawa Y, Sugiura T.
Exosome-Derived microRNAs from Mouthrinse Have the Potential to Be Novel Biomarkers for Sjögren Syndrome. Journal of Personalized Medicine. 2022; 12(9):1483.
https://doi.org/10.3390/jpm12091483
Chicago/Turabian Style
Yamashiro, Kouta, Tomofumi Hamada, Kazuki Mori, Keitaro Nishi, Maya Nakamura, Mahiro Beppu, Akihiko Tanaka, Hiroshi Hijioka, Yoshiaki Kamikawa, and Tsuyoshi Sugiura.
2022. "Exosome-Derived microRNAs from Mouthrinse Have the Potential to Be Novel Biomarkers for Sjögren Syndrome" Journal of Personalized Medicine 12, no. 9: 1483.
https://doi.org/10.3390/jpm12091483
APA Style
Yamashiro, K., Hamada, T., Mori, K., Nishi, K., Nakamura, M., Beppu, M., Tanaka, A., Hijioka, H., Kamikawa, Y., & Sugiura, T.
(2022). Exosome-Derived microRNAs from Mouthrinse Have the Potential to Be Novel Biomarkers for Sjögren Syndrome. Journal of Personalized Medicine, 12(9), 1483.
https://doi.org/10.3390/jpm12091483